Literature DB >> 8944436

A 4-year prospective audit of the cause of death after infrarenal aortic aneurysm surgery.

A J Sandison1, Y Panayiotopoulos, R C Edmondson, M R Tyrrell, P R Taylor.   

Abstract

This study was a 4-year prospective audit of abdominal aortic aneurysm surgery including 222 aneurysm repairs: 106 elective, 76 urgent and 40 emergency. Twenty-five patients died: four who underwent elective surgery, seven urgent and 14 emergency. The two major causes of death, multiple organ failure and colonic ischaemia, were responsible for 11 of the 25 deaths. The three deaths from myocardial infarction all occurred in patients with a leaking aneurysm. Blood loss was significantly higher in patients with multiple organ failure and in those with colonic ischaemia. Methods to identify patients at high risk of massive blood loss and colonic ischaemia may be a way to reduce mortality.

Entities:  

Mesh:

Year:  1996        PMID: 8944436     DOI: 10.1002/bjs.1800831019

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Elective abdominal aortic aneurysm operations--the results of a single surgeon series of 243 consecutive operations from a district general hospital.

Authors:  W V Humphreys; J Byrne; W James
Journal:  Ann R Coll Surg Engl       Date:  2000-01       Impact factor: 1.891

2.  Poor prognostic factors in patients who underwent surgery for acute non-occlusive ischemic colitis.

Authors:  Minsu Noh; Song Soo Yang; Seok Won Jung; Jae Ho Park; Yeong Cheol Im; Kyu Yeol Kim
Journal:  World J Emerg Surg       Date:  2015-03-08       Impact factor: 5.469

3.  Administration of FTY720 during Tourniquet-Induced Limb Ischemia Reperfusion Injury Attenuates Systemic Inflammation.

Authors:  Anthony D Foster; Diego Vicente; Jonathan J Sexton; Luke Johnston; Nick Clark; Crystal Leonhardt; Eric A Elster; Thomas A Davis; Matthew J Bradley
Journal:  Mediators Inflamm       Date:  2017-12-19       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.